Hansen Medical, a company that develops medical systems based on robotics technology for precise three-dimensional control of catheter movement, has released a report that lists about the company’s first-quarter financial results and latest business deals.
The company has signed a contract with Philips for delivering Vascular Robotic System and utilizing the Fiber Optic Shape Sensing and Localization (FOSSL) technology. The company has gained revenue from its Sensei X Robotic Catheter Systems that was first introduced in 2007. A total of 99 Sensei X Robotic Catheter Systems have been transported to various parts of the world.
The company has submitted pre-market approval to the U.S. Food and Drug Administration to evaluate the safety and effectiveness of its Vascular Robotic System and Catheter. The Vascular Robotic System was displayed to doctors and other enthusiasts at major vascular symposiums in Europe.
According to President and Chief Executive Officer of Hansen Medical, Bruce Barclay, the company is taking all initiatives to market themselves commercially, which includes recording catheter shipments for the second successive quarter, recording utilization for the third consecutive quarter, officially launching the Lynx irrigated ablation catheter, displaying the robotic vascular platform in London, and the submitting the 510(k) application for gaining approval of the Vascular Robotic System.